According to Fortress Biotech 's latest financial reports the company's current revenue (TTM) is $84.51 M. In 2022 the company made a revenue of $75.74 M an increase over the years 2021 revenue that were of $68.79 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $84.51 M | 11.58% |
2022 | $75.74 M | 10.11% |
2021 | $68.79 M | 50.86% |
2020 | $45.59 M | 24.49% |
2019 | $36.62 M | -126.51% |
2018 | -$0.14 B | -173.66% |
2017 | $0.18 B | 1038.25% |
2016 | $16.48 M | 1809.62% |
2015 | $0.86 M | |
2014 | N/A | |
2013 | N/A | |
2012 | N/A | |
2011 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Veracyte VCYT | $0.36 B | 327.21% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | $0.19 B | 128.19% | ๐บ๐ธ USA |
Advaxis ADXS | $0.11 M | -99.87% | ๐บ๐ธ USA |
Dynavax Technologies
DVAX | $0.23 B | 174.85% | ๐บ๐ธ USA |